Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06697496 · ClinicalTrials.gov registry record · NA
A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE Trial
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 772
- Enrollment target
NCT06697496 is a NA study that has not yet begun recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 772 participants.
The verdict
NCT06697496, a NA study, has not yet begun recruiting, sponsored by Fred Hutchinson Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 772 participants
- Enrollment target
Study Summary
This clinical trial develops a chatbot smartphone application (app), QuitBot, and text messaging to help American Indians (AI) and Alaska Natives (AN) to quit smoking commercial tobacco (smoking cessation), and evaluates two remote smoking cessation programs to see how well they work for helping AI/AN people quit smoking commercial tobacco. AI/AN populations have one of the highest rates of commercial cigarette smoking of any racial and ethnic group in the United States (US). They also have a higher rate of developing smoking-related cancer but are less likely to quit smoking. The two programs are designed to provide personalized support in setting a smoking cessation goal, tasks to reach the smoking cessation goal, and motivation to remain smoke-free. This may help to keep participants engaged and support them in their quit efforts, and may improve smoking cessation among AI and AN.
Interventions
- OTHER Survey Administration
- OTHER Interview
- PROCEDURE Carbon Monoxide Measurement
- DEVICE QuitBot Smoking Cessation Chatbot Program
- DEVICE QuitBot Smoking Cessation Text Messaging Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 772 participants |
| Start Date | 2026-09-30 |
| Est. Completion | 2030-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06697496
The ClinicalTrials.gov registry entry for NCT06697496 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 772 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.
NCT06697496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06697496 about?
NCT06697496 is a clinical study titled "A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE Trial". This clinical trial develops a chatbot smartphone application (app), QuitBot, and text messaging to help American Indians (AI) and Alaska Natives (AN) to quit smoking commercial tobacco (smoking cessation), and evaluates two remote smoking cessation programs to see how well they work for helping AI/...
What is the current status of trial NCT06697496?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 772 participants. The study started on 2026-09-30. Estimated completion is 2030-10-31.
What interventions are being tested in trial NCT06697496?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Carbon Monoxide Measurement (PROCEDURE), QuitBot Smoking Cessation Chatbot Program (DEVICE), QuitBot Smoking Cessation Text Messaging Program (DEVICE).
Who is sponsoring clinical trial NCT06697496?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.